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Viral respiratory infections in infancy may contribute to the development of airway hyper-responsiveness (AHR) in
childhood but their eects on respiratory function at the adult age are still uncertain. A group of 42 subjects aged
17–35 with a pediatrician-made diagnosis of severe bronchiolitis in infancy (Br) were compared for the presence of
asthma and AHR to a control group (C) paired for age and gender, without evidence of lower respiratory disease in
infancy. All had a respiratory and environmental questionnaire, allergy skin prick tests, blood eosinophil count,
total serum IgE determination and measurements of expiratory flows and airway response to methacholine. In Br
and C groups, respectively, 38 and 12% of subjects had a physician-made diagnosis of asthma, 26 and 7% used
bronchodilators and 12 and 0% an inhaled corticosteroid; 71 and 67%, respectively, were atopic, 50 and 24% were
smokers and 43 and 17% had a first-degree relative with asthma. Mean baseline FEV1 and FEV1/FVC ratio were
lower in the Br than in the C group, with 94/103% (P0002) and 80/87 (P500001) of the predicted value,
respectively. Geometric mean PC20 methacholine was significantly lower in the Br than in the C group 39/203 mg
ml71 (P500001). Mean blood eosinophil count and serum IgE levels were similar in both groups (P4 005).
In conclusion, asthma and AHR were found more frequently in young adults with a past history of bronchiolitis,
suggesting that this type of respiratory infection may contribute to altered pulmonary function in adulthood,
although it may also represent an early manifestation of asthma. The influence of potential confounding factors,
such as familial predisposition and exposure to cigarette smoke on the development of asthma and AHR in the Br
group, cannot be excluded.
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Asthma is a frequent respiratory condition both in children
and adults and is responsible for a marked morbidity (1,2).
Airway hyper-responsiveness (AHR), associated or not
with respiratory symptoms is also frequent in children and
adults (2–4). Bronchiolitis caused by viruses such as the
respiratory syncytial virus (RSV) during the first year of life
seems to be a risk factor for the development of asthma and
sensitization to common allergens during childhood (5–7).
This seems particularly true when children have a past
family history of asthma and atopy, although this relation-
ship is inconsistent (6).Correspondence should be addressed to: Dr Louis-Philippe Boulet,
Hoˆpital Laval, 2725, Chemin Sainte-Foy, Sainte-Foy Que´bec,
Canada, GlV 4G5. Tel: 418-656-4747; Fax: 418-656-4762; E-mail:
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0954-6111/00/030288+07 $35?00/0There is uncertainty as to whether the altered lung
function seen in children after bronchiolitis is the result of
the infection itself or if predisposing factors render the
children more susceptible to either lower respiratory tract
infection (LRTI), post-infectious persistent airway disease,
or both (8). More information is needed on the interactions
between atopic status and respiratory infections in the
development of airway respiratory diseases. In this regard,
animal models showed that allergen sensitization could
potentiate the physiological and structural changes induced
by acute bronchiolitis (9).
Although respiratory infections in infancy can contribute
to the development of asthma and atopy in childhood, their
eects on lung function in adulthood are still to be
determined. It would also be of interest to determine if
some patients have persistent pulmonary function abnorm-
alities and respiratory symptoms for which they have not
consulted a physician.
This study was therefore set up to determine how many
young adults who had bronchiolitis in infancy requiring# 2000 HARCOURT PUBLISHERS LTD
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asthma and AHR, taking into account their atopic status,
family history of asthma/allergy and concomitant exposure
to irritants and allergens.
Methods
SUBJECTS
We evaluated 42 subjects aged 17–35 years with a past
history of bronchiolitis requiring hospital admission in the
first 18 months of life (Br group). They were compared to
control subjects (C group) paired for age and gender,
without previous history of LRTI or other type of non-
infectious respiratory problems in infancy.
Subjects of the Br group fulfilled the following inclusion
criteria: men and women aged between 16–30 years,
hospitalized for an initial episode of bronchiolitis diagnosed
by a pediatrician before the age of 18 months (10). Subjects
whose respiratory symptoms improved following the use of
bronchodilators (they all underwent a trial of this type of
medication) during this episode of bronchiolitis were
excluded as they were considered as possibly having
underlying asthma. Subjects with respiratory diseases other
than asthma, or with contraindications to the proposed
evaluation, were also excluded. All subjects had to indicate
their willingness to participate in the study by signing a
consent form. This study was approved by the local
Institutions Ethics Committee.
STUDY DESIGN
A retrospective analysis of the archived files of the Centre
Hospitalier Universitaire de Que´bec, and of the Hoˆpital du
Saint-Sacrement was done by the local Medical Archives
Departments to find out which subjects, hospitalized with a
diagnosis of bronchiolitis from 1970 to 1980 who agreed to
have their files reviewed, fulfilled the enrollment criteria of
the study. Forty-two consecutive subjects who fulfilled the
inclusion criteria agreeing to be reevaluated were included
in the study. Forty-two consecutive age and gender-paired
control subjects, recruited after analysis of hospital charts
showing no evidence of lower respiratory disease in infancy
or from the same region, were also evaluated.
EVALUATION
On their visit to the Clinical Research Center, each subject
first answered a detailed questionnaire on general health
status and respiratory symptoms, family and personal past
history of asthma or other diseases, past and current
environmental exposure to allergens or irritants and current
or past smoking (either primary or passive).
Skin-prick tests with 26 common airborne allergens were
done to determine atopic status (11). The allergens tested
included cat, dog, horse and cattle hair-dander, feather mix,
several trees, grass and weed pollens, ragweed pollen, house
dust, D. Farinae and various molds. A positive control(histamine) and a negative control for testing non-specific
reactivity of the skin to diluent were also used. Briefly,
droplets of allergen were deposited on the back of the
forearm 25 cm apart, and the skin was gently lifted through
them with a disposable needle (Terumo no 27). For all
subjects the wheal response was read at 10 min and
reported as an absolute value in mm (mean of the largest
diameter and the largest perpendicular to it). A reaction of
3 mm or more was considered as positive.
Spirometry was performed with a Vitalograph spiro-
meter, according to current guidelines (12). The best of
three reproducible measurements was used to calculate the
forced expiratory volume in 1 sec (FEV1). Following
measurements of FEV1 and forced vital capacity (FVC),
airway responsiveness to methacholine was measured
according to the method described by Juniper et al. (13).
The subject inhaled saline (09%) followed by doubling
concentrations of methacholine from 003 to 64 mgml71 if
needed to obtain a 20% fall in FEV1. Methacholine
aerosols were generated by a Wright nebulizer with an
output of 013 mlmin71 and were inhaled for 2 min at 5-
min intervals. The FEV1 was measured 30, 90 and 180 sec
after each inhalation or until it started to increase. The
concentration of methacholine provoking a 20% fall in
FEV1 (PC20) was obtained by linear interpolation on the
log concentration response-curve.
A blood sample for the measurement of serum IgE and
eosinophil count completed the evaluation. IgE determina-
tions were done using particle-enhanced nephelometry
(Behring Nephelometer 100 Analyser) and the eosinophil
count by standard methods on a Coulter ETKS. Finally,
patients had a chest radiograph, if not done in the last 2
years, to exclude any other significant respiratory condi-
tion.
DEFINITIONS
Asthma was defined according to the usual criteria
suggested by the American Thoracic Society (14). Family
history of atopy and asthma refers to a first degree relative
with atopy or symptoms of asthma. Airway hyper-
responsiveness was defined as a PC2058 mgml
71; it was
considered ‘borderline’ between 8 and 16, and normal if
416 mg ml71 with the method used (13). The diagnosis of
bronchiolitis was done according to previously published
criteria, mostly the presence of a syndrome characterized by
wheezing and breathing diculties in a child 518 months
old, following an upper airway infection (10).
ANALYSIS
For analysis, a PC20464 mg ml
71 was considered equal to
64. Means and standard deviations of the mean (SEM) were
determined for continuous variables. Categorical variables
were expressed using the count of the observed event. The
Fisher’s Exact Tests were performed to compare Br with C
groups. For continuous variables, subjects’ characteristics
were compared between Br and C groups using a Student’s
t-test. When the assumption of variances were not
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the degrees of freedom and probability level was obtained
with the Cochran and Cox approximation. This approach
was used when the normality assumptions were met. When
normality and equality of variance assumptions were
rejected, Wilcoxon’s rank sum tests were performed to
compare groups. A logistic regression model was used to
predict the dierent degrees of airway responsiveness
(moderate to severe, mild, borderline and normal) with
subjects’ characteristics. The results were considered
significant if P values were 5005. The data were analysed
using the statistical package program SAS (SAS Institute
Inc., Cary, NC, U.S.A.).
Results
COMPARATIVE CHARACTERISTICS OF
STUDY GROUPS
The demographic and physiological characteristics of the
subjects are summarized in Table 1. Seventy-one per cent
(n30) of subjects with a past history of bronchiolitis (Br
group) and 67% (n28) of control group (C group) were
atopic. In the Br group, 67% (n28) had a positive family
history of atopy (40%, n17 in C group, P002). Fifteen
subjects of each group were sensitized to animals. Of these
subjects, eight were currently exposed to domestic animals
in the Br group and seven in the C group. The prevalence of
smoking was higher in the Br group than in the group C
(respectively, n21 and 10, P002), and 37 subjects had aTABLE 1. Subjects’ characteristics
Bronchi
Number of subjects (gender) 42 (25 F,
Age (+SEM) 21 (+
Atopy 30
Positive family history of atopy 28
Current smoker 21
Positive family history of asthma 18
Diagnosis of asthma (physician made) 16
Actual bronchodilator user 11
Actual inhaled steroid user 5
PC20 geom. mean (mg ml
71) 39
FEV1 mean (% predicted) (+SEM) 94 (+
[ ]* [+0
FVC mean (% predicted) (+SEM) 103 (+
[ ]* [+0
FEV1/FVC mean (% predicted) (+SEM) 80 (+
[ ]* [+0
Eosinophils 109 l71 mean (+SEM) 003 (+0
[ ]* [+000
Total IgE mg l71 mean (+SEM) 365 (+
[ ]* [+2
*95% confidence intervalshistory of passive smoking in their first 3 years of life in the
Br group (25 in the C group) and 16 of them (11 in the C
group) were exposed before birth, their mother having
smoked during pregnancy. In the bronchiolitis group, 18
subjects had a positive family history of asthma (seven in
the C group, P0009). Sixteen out of the 42 Br group
subjects had a physician-made diagnosis of asthma
compared to five in the C group (P001). Bronchodilators
were used by 11 subjects (Br group) and three (C group)
and inhaled corticosteroids by five and 0 subjects respec-
tively. Diagnosis of asthma was made between the ages of
51 to 20 years (mean 88 years) in the bronchiolitis group
and 5 to 23 years in the control group (mean 11 years).
Current symptoms of asthma were present in 31 and 16
subjects from the Br and C groups, respectively.
The mean respective birth weight in the Br compared to
the C groups was 3060 g and 3259 g, duration of pregnancy
was 388 and 393 weeks and eight subjects had been
breastfed in each group (all P4005).
BASELINE PULMONARY FUNCTION TESTS
Baseline airway calibre was reduced in subjects with a past
history of bronchiolitis. The baseline FEV1 values ranged
from 66 to 130% of predicted in the Br group (mean+ SEM;
94+2) and from 85 to 125% in the C group: (mean:
103+1) (P0002). Baseline FVC was 103+2% predicted
in the Br group compared with 102+2% in the C group
(P4005). Baseline FEV1/FVC values were 80+1% in the
Br group and 87+1% in the C group (P5000017).olitis Control group P
17 M) 42 (25 F, 17 M)
05) 22 (+05)
28 4005
17 002
10 002
7 0009
5 001
3 004
0 005
203 500001
2) 103 (+1) 0002
6] [+03]
2) 102 (+2) 4005
6] [+06]
1) 87 (+1) 500001
3] [+03]
003) 002 (+0002) 4005
09] [+00006]
78) 346 (+132) 4005
4] [+41]
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We found an increased number of subjects with airway
hyper-responsiveness in adults who had a past history of
bronchiolitis in infancy in comparison to the control group
(P0002). In all subjects (n84), there was a relationship
between the degree of AHR and blood eosinophil count
(P0001). We found no relationship between PC20 and the
following parameters when analysed separately or by study
group: serum IgE levels, familial history of asthma or
atopy, atopic status, birth weight or secondary smoke
exposure. Although more prevalent in the bronchiolitis
group, smoking and a family history of asthma or atopy
were not predictors of AHR or asthma. These last were not
associated with a familial or maternal history of asthma or
atopy.
PC20 varied from 004 to 464 in the Br group and from
18 to 464 mg ml71 in the C group (geom. mean: 39 and
203, P500001). In the Br and C groups, 26 and 12
subjects had AHR (PC20 58 mg ml
71), seven and six had
‘borderline’ airway responsiveness (8–16 mgml71) and nine
and 24 had a PC20 416 mg ml
71.
When we looked at dierent degrees of airway respon-
siveness in our groups of subjects: PC20 52 mg ml
71
(moderately to severely increased), between 2 to58 (mildly
increased), between 8 to 16 (‘borderline’), and 416 mg
ml71 (normal), and subjects’ characteristics, we found no
association with atopic status, current smoking, family
history of atopy or asthma nor with the degree of airway
responsiveness (P4005, Table 2).
There was a relationship between the degree of airway
responsiveness and corticosteroid inhaler use in the Br
group, subjects on inhaled corticosteroid having the lowest
PC20 (P002). Subjects with a PC20 52 mg ml71 had a
lower FEV1 and FEV1/FVC in both groups (P00004 and
P00001). In the C group, only subjects with a PC20 52
mg ml71 had higher levels of IgE (P00001).
Twenty-six (26)% of non-smokers in the Br group had a
PC20 58 mg ml
71 (36%516 mg ml71) compared to 21TABLE 2. Number of subjects with family or personal history of a
methacholine responsiveness
Moderate
severe AH
PC20(mg ml
71) Group 52
Positive family history of asthma Br 6
C 0
Positive family history of atopy Br 11
C 0
Atopy Br 9
C 1
Passive smoking in the first years of life Br 14
C 1
Maternal smoking Br 7
C 0
Current smoker Br 7
C 0and 31% of non-smokers in the C group. Thirty-six per
cent of smokers in the Br group had a PC20 58 mg ml
71
and 43% had a PC20516 mg ml
71 (7 and 12% of smokers
in the control group). In the Br group, non-smokers had a
lower PC20 compared to the C group (P0007) but FEV1
was similar (P4005). In the Br group, smokers had lower
PC20 and FEV1 than the C group, respectively (P002,
P00006).
BLOOD EOSINOPHIL COUNT AND IGE
LEVEL
There was no significant dierence between either group in
blood eosinophil count and IgE level. Respective means for
these two parameters in the Br group compared to the C
group were 0036109 l71+0003 and 002+0002, and 365
mg l71+78 and 346+132 (P4005, Table 1).
CHEST RADIOGRAPH
The chest radiograph was normal in all subjects.
Discussion
In this study, we found that young adults with a past
history of bronchiolitis requiring hospital admission in
infancy had a reduced baseline airway caliber and more
often had evidence of airway hyper-responsiveness and
symptomatic asthma than a control group of subjects of
similar age and gender without a history of lower
respiratory tract infection in childhood. Although more
prevalent in the bronchiolitis group, smoking and a family
history of asthma or atopy were not predictors of AHR or
asthma.
The influence of bronchiolitis in infancy on pulmonary
function and the prevalence of asthma in childhood has
been studied extensively. However, we know little about thesthma, atopy or smoking in subgroups divided according to
to
R Mild AHR
Borderline
AR
Normal
AR Total
2 to 58 8 to 16 4 16 All subjects
3 3 6 18
2 1 4 7
6 7 4 28
4 2 11 17
10 5 6 30
9 4 14 28
9 6 8 37
6 3 15 25
3 1 5 16
2 2 7 11
8 4 2 21
3 2 5 10
292 V. LAROUCHE ET AL.influence of such disease in adulthood. Although it has been
proposed that viral infections could provide some protec-
tive eect against asthma and allergic diseases (15,16), some
LRTI such as those caused by RSV have been associated
with an increased prevalence of airway obstructive diseases
(17–22). In this regard, our study brings new information
on the long-term consequences of lower respiratory tract
infections in childhood and the potential influence of
concomitant factors on the development of airway diseases.
The most common sequelae of bronchiolitis in infancy is
an increase in airway responsiveness, being reported in
more than half of aected children (18,22–25). Follow-up
of children with previous RSV bronchiolitis up to 10 years
showed a high prevalence of AHR — 57% in the study by
Gurwitz et al. (22). Previous reports showed an increased
prevalence of airway disease at dierent time-periods post-
bronchiolitis, although in most studies the follow-up was
only up to 10 years. A 10 year follow-up of children who
had a past history of RSV infection before age 2 to age 10
and who showed persistent respiratory symptoms, revealed
a reduction in eort tolerance, and airway hyper-respon-
siveness compared to a control group (17,18). At age 10, the
pulmonary function was reduced in children with past RSV
infection compared to others without such infection. The
authors suggested that bronchiolitis in infancy could be an
independent factor of altered pulmonary function.
Although it has been suggested that post-bronchiolitis
AHR can decrease with time in children, our study shows
that AHR and asthma often persist to adulthood. The
determinants of this persistence of asthma to adult age are
still unknown, although factors such as smoking exposure
and atopy seem to be risk factors (2). The possibility that
viral infections in infancy may also contribute to this
persistence has not been fully explored.
The search for RSV was not made in most of the patients
included in our study at the time of their initial bronchiolitis
because there was no such test available to evaluate it at
that time (1970–1980). However, although the diagnosis of
bronchiolitis made by the pediatrician suggests an RSV
infection, as at that time we did not have the diagnostic
tools to confirm the presence of RSV, we may have to deal
with a wheezy lower respiratory tract infection, possibly
due to other viruses (10). RSV is by far the most common
etiologic agent of bronchiolitis in infancy, accounting for
most LRTI before the age of 2 (5).
Many factors may predispose or contribute to the
development of asthma and AHR in children. Atopic
status is one of these, although the dierence in prevalence
of airways abnormalities did not seem related to this last in
our Br group, the prevalence of sensitization to common
allergens being similar to the controls. The Br group
showed, however, an increased prevalence of smoking, both
primary and parental. Smoking-induced airflow obstruc-
tion may contribute to airway hyper-responsiveness, but
this is unlikely in our young adults. On the other hand,
Strachan et al. found that teenagers who appeared to have
outgrown an earlier wheezing tendency remained at risk of
future wheezing, particularly if they took up cigarette
smoking (29). It has also been shown that maternal
smoking could increase the prevalence of respiratorydiseases at that age (30). Exposure to smoke may have
been a contributing factor to the development of asthma
and AHR in the Br group. However, as the number of non-
smoking subjects was relatively small to compare with the
smokers, it is dicult to determine the role of this factor.
The contribution of tobacco exposure is uncertain and may
have an additive eect to the respiratory infection.
In regard to possible genetic factors, children developing
AHR after bronchiolitis seem particularly predisposed to
show persistent respiratory symptoms after this infection if
they were the ospring of parents with atopic illnesses
(7,8,26,31). In our group of young adults with past
bronchiolitis, although the prevalence of a family history
of asthma was higher in the Br group, it was not a
predicting factor.
Although viral respiratory infection could have contrib-
uted to the development of asthma and AHR in our Br
group, the clinical presentation of bronchiolitis could have
been a manifestation of asthma. Martinez et al. showed in a
cohort of infants followed from birth that most children up
to 2 years old who presented some wheezing, often
associated with lower respiratory infection, had a transient
reduction of pulmonary function, but no increased risk of
asthma in the future (26). A minority of these children,
however, develop asthma after such infection and this
tendency is associated with predisposing factors such as a
maternal history of asthma, elevated IgE levels and reduced
baseline pulmonary function (26). In our study even if we
chose infants without evidence of a response to a
bronchodilator during the initial bronchiolitis, the persis-
tence of airway function changes could have been related to
an early manifestation of asthma or to a predisposition to
develop this disease.
However, even if post-bronchiolitis persistent airway
disease reflects predisposing factors, viral infection may
also have contributed to these abnormalities (32,33).
Viruses may induce bronchial damage and airway remodel-
ing such that pulmonary function will be altered and the
level of airway responsiveness could increase. In this regard,
it has been found in animal models that RSV can
chronically persist in the lungs and that aected animals
develop an anti-RSV IgG1 immunoglobulin 1 antibody
response with histological evidence of acute bronchiolitis,
and chronic airway inflammation (34). Furthermore, it is
possible that RSV may induce an asthma-like condition
and RSV-specific IgE in infected infants as a result of a
Th2-like response to RSV (35,36).
In our study, we tried to avoid selection biases in
studying the 42 first consecutive subjects hospitalized for
bronchiolitis in the past who agreed to participate to the
study. In regard to the control group, these subjects were
from the same population as subjects with bronchiolitis.
Although we realize that it is dicult to know if AHR
preceded or followed bronchiolitis, comparison with the
control group suggests a relationship between AHR and the
severe episode of bronchiolitis. We, however, chose to
exclude children with an initial bronchodilator response
suggesting asthma to try to reduce the possibility of
concurrent asthma. The results of this study therefore only
apply to this population.
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asymptomatic may still have persistent function abnormal-
ities (37). On the other hand, symptoms suggestive of
asthma could also be present many years before the
diagnosis was made (38). Another interesting observation
of this study is that many subjects were not aware that they
had asthma and therefore did not seek medical help. This
stresses the fact that physicians, as well as subjects with a
past history of bronchiolitis, particularly in the presence of
other predisposing factors to develop asthma, should be
made aware of the increased risk of asthma, in order to
oer appropriate therapy if it develops.
Finally, the prevalence of AHR may seem high in our
control group but it is close to what has been found in our
population. Even if controls had significant AHR, it was
much higher in our bronchiolitis group. In regard to atopy,
it is a frequent finding in our population when defined as at
least one positive response to a battery of common airborne
allergens, being as high as 60 to 76% (39,40). So, our results
are consistent with these figures.
In conclusion, the study suggests that LRTI in infancy,
particularly when associated with other factors predispos-
ing to asthma and AHR may have consequences on airway
function until the adult age. Further studies are required to
determine the exact influence of LRTI in childhood on
long-term airway function and structure and the mechan-
isms leading to these problems. Adults with a past history
of bronchiolitis in infancy should be aware of the possibly
increased risk of asthma. Finally, the potential for early
interventions to prevent airways disorders should be
investigated.
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